These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29440456)

  • 21. Glomerular-specific protein kinase C-β-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity.
    Mima A; Ohshiro Y; Kitada M; Matsumoto M; Geraldes P; Li C; Li Q; White GS; Cahill C; Rask-Madsen C; King GL
    Kidney Int; 2011 Apr; 79(8):883-96. PubMed ID: 21228767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin accelerates wound healing in type 2 diabetic db/db mice.
    Han X; Tao Y; Deng Y; Yu J; Sun Y; Jiang G
    Mol Med Rep; 2017 Dec; 16(6):8691-8698. PubMed ID: 28990070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ginsenoside (Rg-1) promoted the wound closure of diabetic foot ulcer through iNOS elevation via miR-23a/IRF-1 axis.
    Cai HA; Huang L; Zheng LJ; Fu K; Wang J; Hu FD; Liao RY
    Life Sci; 2019 Sep; 233():116525. PubMed ID: 31158376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.
    Koya D; Jirousek MR; Lin YW; Ishii H; Kuboki K; King GL
    J Clin Invest; 1997 Jul; 100(1):115-26. PubMed ID: 9202063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition.
    Tuttle KR; Anderson PW
    Am J Kidney Dis; 2003 Sep; 42(3):456-65. PubMed ID: 12955673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral targeting of protein kinase C receptor: promising route for diabetic retinopathy?
    Pathak D; Gupta A; Kamble B; Kuppusamy G; Suresh B
    Curr Drug Deliv; 2012 Jul; 9(4):405-13. PubMed ID: 22520069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ruboxistaurin: LY 333531.
    Drugs R D; 2007; 8(3):193-9. PubMed ID: 17472415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of San-huang-sheng-fu oil on peripheral circulatory disorders and foot ulcers in diabetic rats and the mechanisms].
    Wan Y; Yang YJ; Li YS; Li XJ; Zhang W; Liu M; Tang HB
    Zhonghua Shao Shang Za Zhi; 2016 Mar; 32(3):168-75. PubMed ID: 27030654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PKCβ/NF-κB pathway in diabetic atrial remodeling.
    Wang H; Xu Y; Xu A; Wang X; Cheng L; Lee S; Tse G; Li G; Liu T; Fu H
    J Physiol Biochem; 2020 Nov; 76(4):637-653. PubMed ID: 33085045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 20(S)-Protopanaxadiol enhances angiogenesis via HIF-1α-mediated VEGF secretion by activating p70S6 kinase and benefits wound healing in genetically diabetic mice.
    Zhang EY; Gao B; Shi HL; Huang LF; Yang L; Wu XJ; Wang ZT
    Exp Mol Med; 2017 Oct; 49(10):e387. PubMed ID: 29075038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective inhibition of PKCβ2 preserves cardiac function after myocardial infarction and is associated with improved angiogenesis of ischemic myocardium in diabetic rats.
    Wang F; Huang D; Zhu W; Li S; Yan M; Wei M; Li J
    Int J Mol Med; 2013 Nov; 32(5):1037-46. PubMed ID: 24002353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasculoprotective effects of combined endothelial progenitor cells and mesenchymal stem cells in diabetic wound care: their potential role in decreasing wound-oxidative stress.
    Sukpat S; Isarasena N; Wongphoom J; Patumraj S
    Biomed Res Int; 2013; 2013():459196. PubMed ID: 23844362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophil Extracellular Traps Delay Diabetic Wound Healing by Inducing Endothelial-to-Mesenchymal Transition via the Hippo pathway.
    Yang S; Wang S; Chen L; Wang Z; Chen J; Ni Q; Guo X; Zhang L; Xue G
    Int J Biol Sci; 2023; 19(1):347-361. PubMed ID: 36594092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A PKC-beta inhibitor protects against cardiac microvascular ischemia reperfusion injury in diabetic rats.
    Wei L; Sun D; Yin Z; Yuan Y; Hwang A; Zhang Y; Si R; Zhang R; Guo W; Cao F; Wang H
    Apoptosis; 2010 Apr; 15(4):488-98. PubMed ID: 20044781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of Type 1 diabetic mice.
    Graiani G; Emanueli C; Desortes E; Van Linthout S; Pinna A; Figueroa CD; Manni L; Madeddu P
    Diabetologia; 2004 Jun; 47(6):1047-54. PubMed ID: 15164170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.
    Casellini CM; Barlow PM; Rice AL; Casey M; Simmons K; Pittenger G; Bastyr EJ; Wolka AM; Vinik AI
    Diabetes Care; 2007 Apr; 30(4):896-902. PubMed ID: 17392551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach.
    Liu Q; Chen X; Macdonnell SM; Kranias EG; Lorenz JN; Leitges M; Houser SR; Molkentin JD
    Circ Res; 2009 Jul; 105(2):194-200. PubMed ID: 19556521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular Endothelial Growth Factor Receptor Type 1 Signaling Prevents Delayed Wound Healing in Diabetes by Attenuating the Production of IL-1β by Recruited Macrophages.
    Okizaki S; Ito Y; Hosono K; Oba K; Ohkubo H; Kojo K; Nishizawa N; Shibuya M; Shichiri M; Majima M
    Am J Pathol; 2016 Jun; 186(6):1481-98. PubMed ID: 27085138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications.
    Joy SV; Scates AC; Bearelly S; Dar M; Taulien CA; Goebel JA; Cooney MJ
    Ann Pharmacother; 2005 Oct; 39(10):1693-9. PubMed ID: 16160002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical application of substance P promotes wound healing in streptozotocin-induced diabetic rats.
    Kant V; Kumar D; Kumar D; Prasad R; Gopal A; Pathak NN; Kumar P; Tandan SK
    Cytokine; 2015 May; 73(1):144-55. PubMed ID: 25748837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.